BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 38002942)

  • 21. Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic.
    Lipton LR; Johnson V; Cummings C; Fisher S; Risby P; Eftekhar Sadat AT; Cranston T; Izatt L; Sasieni P; Hodgson SV; Thomas HJ; Tomlinson IP
    J Clin Oncol; 2004 Dec; 22(24):4934-43. PubMed ID: 15611508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lynch syndrome: clinical, pathological, and genetic insights.
    Schneider R; Schneider C; Kloor M; Fürst A; Möslein G
    Langenbecks Arch Surg; 2012 Apr; 397(4):513-25. PubMed ID: 22362054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.
    Mills AM; Liou S; Ford JM; Berek JS; Pai RK; Longacre TA
    Am J Surg Pathol; 2014 Nov; 38(11):1501-9. PubMed ID: 25229768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Missed opportunities: Genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer.
    Lee J; Gubernick LR; Brodsky AL; Fehniger JE; Levine DA; Gerber D; Asgari SA; Cantor A; Martineau JT; Ginsburg OM; Smith JA; Pothuri B
    Gynecol Oncol; 2018 Oct; 151(1):153-158. PubMed ID: 30077346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.
    Stoffel EM; Mangu PB; Gruber SB; Hamilton SR; Kalady MF; Lau MW; Lu KH; Roach N; Limburg PJ; ;
    J Clin Oncol; 2015 Jan; 33(2):209-17. PubMed ID: 25452455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Can an online risk assessment tool for identification of hereditary colorectal cancer reach the at-risk population and influence screening compliance?].
    Schürmanns K; Gelos M; Felder G; Schneider R; Möslein G
    Dtsch Med Wochenschr; 2014 May; 139(18):935-40. PubMed ID: 24760714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lynch syndrome associated endometrial carcinomas in Western Australia: an analysis of universal screening by mismatch repair protein immunohistochemistry.
    Gupta S; Nichols CB; Phillips J; O'Sullivan S; Ayres C; Mohan GR; Leung Y; Stewart CJR; Tan A; Schofield L; Salfinger SG; Kiraly-Borri C; Pachter N; Cohen PA
    Int J Gynecol Cancer; 2021 Jun; 31(6):846-851. PubMed ID: 33858951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occult endometrial cancer and decision making for prophylactic hysterectomy in hereditary nonpolyposis colorectal cancer patients.
    Pistorius S; Kruger S; Hohl R; Plaschke J; Distler W; Saeger HD; Schackert HK
    Gynecol Oncol; 2006 Aug; 102(2):189-94. PubMed ID: 16476474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
    Soliman PT; Broaddus RR; Schmeler KM; Daniels MS; Gonzalez D; Slomovitz BM; Gershenson DM; Lu KH
    J Clin Oncol; 2005 Dec; 23(36):9344-50. PubMed ID: 16361634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and histomolecular endometrial tumor characterization of patients at-risk for Lynch syndrome in South of Brazil.
    Cossio SL; Koehler-Santos P; Pessini SA; Mónego H; Edelweiss MI; Meurer L; Errami A; Coffa J; Bock H; Saraiva-Pereira ML; Ashton-Prolla P; Prolla JC
    Fam Cancer; 2010 Jun; 9(2):131-9. PubMed ID: 19821155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lynch syndrome and related familial colorectal cancers.
    Abdel-Rahman WM; Peltomäki P
    Crit Rev Oncog; 2008; 14(1):1-22; discussion 23-31. PubMed ID: 19105568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA mismatch repair deficiency and hereditary syndromes in Latino patients with colorectal cancer.
    Ricker CN; Hanna DL; Peng C; Nguyen NT; Stern MC; Schmit SL; Idos GE; Patel R; Tsai S; Ramirez V; Lin S; Shamasunadara V; Barzi A; Lenz HJ; Figueiredo JC
    Cancer; 2017 Oct; 123(19):3732-3743. PubMed ID: 28640387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families.
    Steinke V; Holzapfel S; Loeffler M; Holinski-Feder E; Morak M; Schackert HK; Görgens H; Pox C; Royer-Pokora B; von Knebel-Doeberitz M; Büttner R; Propping P; Engel C;
    Int J Cancer; 2014 Jul; 135(1):69-77. PubMed ID: 24493211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
    Chao X; Li L; Wu M; Ma S; Tan X; Zhong S; Bi Y; Lang J
    Cancer Commun (Lond); 2019 Jul; 39(1):42. PubMed ID: 31307542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lynch or not Lynch? Is that always a question?
    Colas C; Coulet F; Svrcek M; Collura A; Fléjou JF; Duval A; Hamelin R
    Adv Cancer Res; 2012; 113():121-66. PubMed ID: 22429854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of DNA repair protein in colorectal cancer of patients up to 50 years old can increase the identification of Lynch syndrome?
    Germini DE; Mader AM; Gomes LG; Teodoro TR; Franco MI; Waisberg J
    Tumour Biol; 2016 Feb; 37(2):2757-64. PubMed ID: 26408182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline variation in the oxidative DNA repair genes NUDT1 and OGG1 is not associated with hereditary colorectal cancer or polyposis.
    Mur P; Jemth AS; Bevc L; Amaral N; Navarro M; Valdés-Mas R; Pons T; Aiza G; Urioste M; Valencia A; Lázaro C; Moreno V; Puente XS; Stenmark P; Warpman-Berglund U; Capellá G; Helleday T; Valle L
    Hum Mutat; 2018 Sep; 39(9):1214-1225. PubMed ID: 29900613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1.
    Syngal S; Fox EA; Eng C; Kolodner RD; Garber JE
    J Med Genet; 2000 Sep; 37(9):641-5. PubMed ID: 10978352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive molecular characterisation of hereditary non-polyposis colorectal tumours with mismatch repair proficiency.
    Bellido F; Pineda M; Sanz-Pamplona R; Navarro M; Nadal M; Lázaro C; Blanco I; Moreno V; Capellá G; Valle L
    Eur J Cancer; 2014 Jul; 50(11):1964-72. PubMed ID: 24841217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial Cancer.
    Ramchander NC; Ryan NAJ; Walker TDJ; Harries L; Bolton J; Bosse T; Evans DG; Crosbie EJ
    Front Immunol; 2019; 10():3023. PubMed ID: 31998307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.